Quintiles Phase I Services — Overland Park, Kansas

Quintiles Phase I Services is a clinical research site located in Overland Park, Kansas, United States 66211.

Crixeo Health Trust Score: 73/100 (FAIR). This profile has not yet been claimed by the site owner.

Quintiles Phase I Services has participated in 8 clinical trials.

Therapeutic areas: TB Multi-drug Resistant, Anthrax, Ebola Hemorrhagic Fever.

Sponsors: National Institute of Allergy and Infectious Diseases (NIAID), PharmAthene, Inc., Sarepta Therapeutics, Inc..

Sponsor Feasibility Report

Trust Score: 73/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Quintiles Phase I Services?

Quintiles Phase I Services has a Crixeo Trust Score of 73/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Quintiles Phase I Services conducted?

Quintiles Phase I Services has 8 clinical trials on record. Their work covers TB Multi-drug Resistant, Anthrax, Ebola Hemorrhagic Fever.

Is Quintiles Phase I Services accredited by Crixeo Health?

Yes — Quintiles Phase I Services holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Quintiles Phase I Services?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.